The population of the US is not vaccinated but many immigrants who enter the US do have a BCG vaccination. These people are also at the lower end of the economy are are susceptible to latent TB being activated.
In my research I did find a paper that questioned the effectiveness of the proteins being used in QF-1. Moreover, there needed to be a powerful impetus to change from the established skin test. I was not fully convinced that QF-1 had the muscle to drive the change.
On the other hand the link to SSI has resulted in QF-Gold which does satisfy my criteria. It also extends the patents [courtesy of SSI]. This removes the risk of a generic test after only several years of marketing QF-1 by CST.
QF-Gold has technical and commercial advantages that puts QF-1 in the shade. The wait may be longer but the benefits are greater.
- Forums
- ASX - By Stock
- CST
- hmmm.
hmmm., page-8
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.90M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6699 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 331144 | 3 |
Last trade - 10.27am 04/12/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
Day chart unavailable